Zdrowie i gospodarka · 03/02/2000

FDA Releases Guidance for Industry on Skin Irritation and Sensitization Testing of Generic Transdermal Drug Products

The Food and Drug Administration (FDA) has published a guidance document to help generic drug manufacturers assess skin irritation and sensitization in their transdermal products, which can impact drug absorption and efficacy